| Patients on no medical treatment n = 37 | Patients on medical treatment n = 32 | Healthy children n = 16 |
---|---|---|---|
Female sex, n (%) | 25 (68) | 22 (69) | 2 (12) |
Age at disease onset, years, median (IQR) | 6.8 (2.7–12.6) | 4.0 (2.6–11.4) |  |
Age at sampling, years, median (IQR) | 9.9 (5.4–15.2) | 12.8 (9.6–14.6) | 5.3, (2.0–9.5)** |
JADAS27 score | 8.6 (5.8–12.8) (n = 34) | 4.3 (1.3–8.1) (n = 29)* |  |
JIA categories, course type | Number | Number | Â |
Oligoarticular persistent | 18 | 12 | Â |
Oligoarticular extended | 3 | 3 | Â |
Enthesitis-related arthritis | 6 | 1 | Â |
Polyarticular RF negative | 6 | 8 | Â |
Juvenile psoriatic arthritis | 3 | 3 | Â |
Undifferentiated arthritis | 1 | 5 | Â |
Medical treatment | Â | Number | Â |
Methotrexate | Â | 14 | Â |
Biological agent | Â | 7 | Â |
Biological agent + methotrexate | Â | 11 | Â |